Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$40.97|
|52 Week High||US$18.22|
|52 Week Low||US$60.36|
|1 Month Change||-13.05%|
|3 Month Change||-19.86%|
|1 Year Change||114.50%|
|3 Year Change||101.82%|
|5 Year Change||212.75%|
|Change since IPO||192.64%|
Recent News & Updates
Is Cutera (NASDAQ:CUTR) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Cutera's (NASDAQ:CUTR) Promising Earnings May Rest On Soft Foundations
Cutera, Inc. ( NASDAQ:CUTR ) announced strong profits, but the stock was stagnant. Our analysis suggests that...
|CUTR||US Medical Equipment||US Market|
Return vs Industry: CUTR exceeded the US Medical Equipment industry which returned 24.4% over the past year.
Return vs Market: CUTR exceeded the US Market which returned 33.4% over the past year.
Stable Share Price: CUTR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: CUTR's weekly volatility (4%) has been stable over the past year.
About the Company
Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women’s intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity.
Cutera Fundamentals Summary
|CUTR fundamental statistics|
Is CUTR overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CUTR income statement (TTM)|
|Cost of Revenue||US$86.02m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
Nov 03, 2021
|Earnings per share (EPS)||0.41|
|Net Profit Margin||3.71%|
How did CUTR perform over the long term?See historical performance and comparison
Is Cutera undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CUTR ($40.97) is trading below our estimate of fair value ($146.56)
Significantly Below Fair Value: CUTR is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CUTR is poor value based on its PE Ratio (100.5x) compared to the US Medical Equipment industry average (49.9x).
PE vs Market: CUTR is poor value based on its PE Ratio (100.5x) compared to the US market (18.1x).
Price to Earnings Growth Ratio
PEG Ratio: CUTR is poor value based on its PEG Ratio (44x)
Price to Book Ratio
PB vs Industry: CUTR is overvalued based on its PB Ratio (13.8x) compared to the US Medical Equipment industry average (4.3x).
How is Cutera forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CUTR's forecast earnings growth (2.3% per year) is above the savings rate (2%).
Earnings vs Market: CUTR's earnings (2.3% per year) are forecast to grow slower than the US market (14.7% per year).
High Growth Earnings: CUTR's earnings are forecast to grow, but not significantly.
Revenue vs Market: CUTR's revenue (15.3% per year) is forecast to grow faster than the US market (9.9% per year).
High Growth Revenue: CUTR's revenue (15.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CUTR's Return on Equity is forecast to be high in 3 years time
How has Cutera performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CUTR has a large one-off gain of $6.4M impacting its June 30 2021 financial results.
Growing Profit Margin: CUTR became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: CUTR has become profitable over the past 5 years, growing earnings by -36.8% per year.
Accelerating Growth: CUTR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: CUTR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (36.1%).
Return on Equity
High ROE: CUTR's Return on Equity (13.7%) is considered low.
How is Cutera's financial position?
Financial Position Analysis
Short Term Liabilities: CUTR's short term assets ($238.6M) exceed its short term liabilities ($60.3M).
Long Term Liabilities: CUTR's short term assets ($238.6M) exceed its long term liabilities ($150.5M).
Debt to Equity History and Analysis
Debt Level: CUTR's debt to equity ratio (250.8%) is considered high.
Reducing Debt: Insufficient data to determine if CUTR's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: CUTR's debt is not well covered by operating cash flow (4.4%).
Interest Coverage: CUTR's interest payments on its debt are not well covered by EBIT (1.4x coverage).
What is Cutera current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CUTR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CUTR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CUTR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CUTR's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CUTR's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Dave Mowry (59 yo)
Mr. David H. Mowry, also known as Dave, has been Independent Director of Alphatec Holdings, Inc. (alternative name Alphatec Spine, Inc.) since February 8, 2017. He is the Chief Executive Officer and Direct...
CEO Compensation Analysis
Compensation vs Market: Dave's total compensation ($USD1.33M) is below average for companies of similar size in the US market ($USD2.26M).
Compensation vs Earnings: Dave's compensation has been consistent with company performance over the past year.
Experienced Management: CUTR's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Experienced Board: CUTR's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CUTR insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Cutera, Inc.'s employee growth, exchange listings and data sources
- Name: Cutera, Inc.
- Ticker: CUTR
- Exchange: NasdaqGS
- Founded: 1988
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$735.102m
- Shares outstanding: 17.94m
- Website: https://cutera.com
Number of Employees
- Cutera, Inc.
- 3240 Bayshore Boulevard
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/27 22:56|
|End of Day Share Price||2021/10/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.